» Articles » PMID: 36754940

Recent Updates of Stem Cell-based Erythropoiesis

Overview
Journal Hum Cell
Publisher Springer
Specialty Cell Biology
Date 2023 Feb 8
PMID 36754940
Authors
Affiliations
Soon will be listed here.
Abstract

Blood transfusions are now an essential part of modern medicine. Transfusable red blood cells (RBCs) are employed in various therapeutic strategies; however, the processes of blood donation, collection, and administration still involve many limitations. Notably, a lack of donors, the risk of transfusion-transmitted disease, and recent pandemics such as COVID-19 have prompted us to search for alternative therapeutics to replace this resource. Originally, RBC production was attempted via the ex vivo differentiation of stem cells. However, a more approachable and effective cell source is now required for broader applications. As a viable alternative, pluripotent stem cells have been actively used in recent research. In this review, we discuss the basic concepts related to erythropoiesis, as well as early research using hematopoietic stem cells ex vivo, and discuss the current trend of in vitro erythropoiesis using human-induced pluripotent stem cells.

Citing Articles

PROTAC-mediated vimentin degradation promotes terminal erythroid differentiation of pluripotent stem cells.

Yan H, Zang R, Cui T, Liu Y, Zhang B, Zhao L Stem Cell Res Ther. 2024; 15(1):310.

PMID: 39294765 PMC: 11412063. DOI: 10.1186/s13287-024-03910-1.


Single-cell multi-omics reveal stage of differentiation and trajectory-dependent immunity-related gene expression patterns in human erythroid cells.

Perik-Zavodskii R, Perik-Zavodskaia O, Alrhmoun S, Volynets M, Shevchenko J, Nazarov K Front Immunol. 2024; 15:1431303.

PMID: 39267736 PMC: 11390661. DOI: 10.3389/fimmu.2024.1431303.


Progresses in overcoming the limitations of in vitro erythropoiesis using human induced pluripotent stem cells.

Ju H, Sohn Y, Nam Y, Rim Y Stem Cell Res Ther. 2024; 15(1):142.

PMID: 38750578 PMC: 11094930. DOI: 10.1186/s13287-024-03754-9.


Biological response of nonhuman primates to controlled levels of acute blood loss.

Roh J, Park E, Lee H, Hwang J, Kim H, Park J Front Immunol. 2024; 14:1286632.

PMID: 38268927 PMC: 10806063. DOI: 10.3389/fimmu.2023.1286632.

References
1.
Greinacher A, Fendrich K, Hoffmann W . Demographic Changes: The Impact for Safe Blood Supply. Transfus Med Hemother. 2010; 37(3):141-148. PMC: 2914426. DOI: 10.1159/000313949. View

2.
Khan F, Singh K, Friedman M . Artificial Blood: The History and Current Perspectives of Blood Substitutes. Discoveries (Craiova). 2020; 8(1):e104. PMC: 7086064. DOI: 10.15190/d.2020.1. View

3.
Douay L, Lapillonne H, Turhan A . Stem cells--a source of adult red blood cells for transfusion purposes: present and future. Crit Care Clin. 2009; 25(2):383-98, Table of Contents. DOI: 10.1016/j.ccc.2008.12.008. View

4.
Lapillonne H, Kobari L, Mazurier C, Tropel P, Giarratana M, Zanella-Cleon I . Red blood cell generation from human induced pluripotent stem cells: perspectives for transfusion medicine. Haematologica. 2010; 95(10):1651-9. PMC: 2948089. DOI: 10.3324/haematol.2010.023556. View

5.
Barminko J, Reinholt B, Baron M . Development and differentiation of the erythroid lineage in mammals. Dev Comp Immunol. 2015; 58:18-29. PMC: 4775370. DOI: 10.1016/j.dci.2015.12.012. View